Delcath Systems (DCTH) Land & Improvements (2011 - 2012)

Delcath Systems' (DCTH) quarterly Land & Improvements came in at $154000.0 in Q3 2012, little changed quarter-over-quarter from $154000.0 in Q2 2012.

Delcath Systems (DCTH) Land & Improvements (2011 - 2012) Analysis & Trends

Delcath Systems' Land & Improvements history runs 2 years deep, the most recent figure standing at $154000.0 for Q3 2012.

On a quarterly basis, Land & Improvements changed N/A year-over-year to $154000.0 in Q3 2012; TTM through Sep 2012 was $154000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $154000.0, changed N/A from the prior year.
Land & Improvements was little changed at $154000.0 in Q3 2012 per DCTH's latest filing, from $154000.0 in the prior quarter.
Across five years, Land & Improvements topped out at $154000.0 in Q4 2011 and bottomed at $154000.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Land & Improvements (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	1.80 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	188.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Delcath Systems	16,569.19	-89.28 Mn	21.26 Mn	-

Download Data